Since October 2020 – when the Health Sciences Authority (HSA) first authorised sale of an esketamine nasal spray for serious depression – five psychiatrists who used the therapy on their patients have ...
Klaria Pharma Holding AB (publ) ("Klaria" or the "Company") announces that the Company has signed a license agreement for Sumatriptan Alginate Film (the "Product"), a pharmaceutical product based on K ...